Ann Dermatol.  2016 Apr;28(2):257-259. 10.5021/ad.2016.28.2.257.

Erythema Annulare Centrifugum: Analysis of Associated Diseases and Clinical Outcomes according to Histopathologic Classification

• Kim DH
• Lee JH
• Lee JY
• Park YM

• KMID: 2171391
• DOI: http://doi.org/10.5021/ad.2016.28.2.257

Abstract

No abstract available.

MeSH Terms

Classification*
Erythema*

Reference

1. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill;2012. p. 463–466.

2. Helbling I, Walewska R, Dyer MJ, Bamford M, Harman KE. Erythema annulare centrifugum associated with chronic lymphocytic leukaemia. Br J Dermatol. 2007; 157:1044–1045.

3. Kim KJ, Chang SE, Choi JH, Sung KJ, Moon KC, Koh JK. Clinicopathologic analysis of 66 cases of erythema annulare centrifugum. J Dermatol. 2002; 29:61–67.

4. Weyers W, Diaz-Cascajo C, Weyers I. Erythema annulare centrifugum: results of a clinicopathologic study of 73 patients. Am J Dermatopathol. 2003; 25:451–462.

5. Ziemer M, Eisendle K, Zelger B. New concepts on erythema annulare centrifugum: a clinical reaction pattern that does not represent a specific clinicopathological entity. Br J Dermatol. 2009; 160:119–126.

6. Aubin F, Porcher R, Jeanmougin M, Léonard F, Bedane C, Moreau A, Société Française de Photodermatologie, et al. Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study. J Am Acad Dermatol. 2014; 71:948–953.e1.